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Chronic abdominal and pelvic pain is a debilitating problem that afflicts 15-20% of reproductive age 
women (Ayorinde A et al. Eur J Pain 2017; 21:445-455). The potential etiologies are diverse and often 
reflect pathology in one or more organ system. While there has been substantial progress in providing 
effective care for women with chronic pain, current treatment strategies continue to be limited by 
incomplete response and high recurrence rates. One of the most significant barriers to developing a 
patient-centered, personalized treatment approach is our limited understanding of the various 
mechanisms underlying the pathogenesis of pain in this poorly understood and heterogeneous 
condition. 
Among the numerous causes of chronic pain, abdominal wall pain is a prevalent but under-recognized 
and poorly understood source. In this month’s edition of BJOG, Poli-Neto et al report electromyographic 
characteristics of presumed trigger points in women with chronic abdominal wall pain following 
cesarean section and provide an important step towards defining a personalized, mechanism-based 
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trigger points after cesarean section and then treated them with weekly lidocaine injections for 4 weeks.  
They found that abnormal electromyography findings prior to injections (which were present in 15 
women) was associated with a significantly higher likelihood of pain improvement 1 week and 3 months 
after lidocaine injections.   
This study highlights an important barrier in clinical care and research studies of chronic abdominal and 
pelvic pain.  As the authors correctly point out, there are no uniform, objective diagnostic criteria for 
many presumed etiologies of chronic pain.  In the case of abdominal wall pain, distinguishing pain due to 
generalized myofascial pain, focal trigger point, abdominal wall neuropathy, or referred pain due to an 
underlying visceral cause is currently based on clinical history and exam findings without objective 
diagnostic criteria.  However, the symptoms and exam findings of these diagnoses often overlap, leaving 
clinicians to empirically treat overlapping conditions with multiple or non-specific therapies. Identifying 
a reproducible and standardized test to define the mechanism of pain and predict which treatments are 
most likely to succeed, like the present study attempts to do, will greatly improve our ability to provide 
personalized treatment plans to patients with chronic pain. 
While these findings provide insight into the pathophysiology of abdominal wall pain and suggest that 
mechanism-based treatment recommendations may be feasible, applicability of these results to broader 
populations of women with chronic abdominal pain are limited due to the exclusion of patients with 
concomitant endometriosis, painful bladder syndrome, or irritable bowel syndrome, all of which 
frequently co-occur with trigger points.  Efficacy and mechanistic studies, such as this, are highly 
manicured and do not reflect most clinical populations. In reality, most women with chronic abdominal-
pelvic pain have more than one cause of pain.  As such, findings from these studies are not consistently 
reproducible in real world practice.  However, these studies are important first steps towards identifying 
personalized care strategies for chronic pain.   
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